Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Senda hires COO and general counsel

Plus Raineri becomes CTO at Aspen, and updates from Evozyne, Nabsys, AnHeart and IDSA

October 20, 2022 12:32 AM UTC

Flagship-backed company Senda Biosciences Inc. hired Lori Rudolph-Owen as COO and Barbara Bispham as SVP, general counsel. Rudolph-Owen was chief development officer at Goldfinch Bio Inc., before which he was VP of portfolio management and assessment at Tesaro Inc. Bispham was VP, head of legal at BridgeBio Pharma Inc. (NASDAQ:BBIO).

Aspen Neuroscience Inc. hired Kim Raineri as CTO. Raineri was chief manufacturing and technology officer at Avrobio Inc. (NASDAQ:AVRO). Aspen is aiming to advance its autologous stem cell-derived Parkinson’s disease therapy into clinical trials next year...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article